CBCT imaging

DEVICE5 trials

Sponsors

Cairo University, Maastricht Radiation Oncology, Varian, a Siemens Healthineers Company

Conditions

Breast CancerDiagnosisDose ReductionHead and Neck CancerLiver CancerLung CancerMandibular Canal VisibilityOther Cancer

Unknown Phase

Assessment of Mandibular Osseous Changes in Patients With End Stage Renal Failure

Cairo UniversityDiagnosis

Start: 2017-08-31End: 2017-11-30Target: 26Updated: 2017-07-19

Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

CompletedNCT03385031

Maastricht Radiation OncologyBreast Cancer

Start: 2018-01-01End: 2018-08-20Updated: 2019-03-08

Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy

CompletedNCT05176860

Varian, a Siemens Healthineers CompanyBreast Cancer, Liver Cancer, Lung Cancer +1

Start: 2022-12-20End: 2023-07-30Updated: 2026-08-26

On-treatment Adaptation of Head and Neck Cancer Dosimetry Plans Using Novel Cone-beam CT and AI-driven Software

CompletedNCT05666193

Varian, a Siemens Healthineers CompanyHead and Neck Cancer

Start: 2023-07-10End: 2024-12-19Updated: 2025-02-04

Effect of CBCT Dose Reduction on the Mandibular Canal Visibility Compared to Standard CBCT Dose Diagnostic Accuracy Study

CompletedNCT07442474

Cairo UniversityDose Reduction, Mandibular Canal Visibility

Start: 2023-01-04End: 2024-05-20Updated: 2026-03-02

Related Papers

Automatic dose verification system for breast radiotherapy: Method validation, contour propagation and DVH parameters evaluation.

2022-03-311 citations